- This event has passed.
Science Headlines: The Race to End the Pandemic—COVID-19 Vaccine Trials in Kansas City
June 2, 2020, 4:00 pm - 5:00 pm
With thousands of deaths across the globe and the world in the midst of an economic shutdown, the race is on to create a COVID-19 vaccine, and a medical research lab in Kansas City has become ground zero for coronavirus vaccination testing.
In April, Inovio Pharmaceuticals became the second U.S. company to begin human trials for a COVID-19 vaccine. The trials involve 80 healthy volunteers at two sites, one in Philadelphia and the other in Kansas City at the Center for Pharmaceutical Research, an AMR company. The novel DNA-based vaccine, created by Inovio researchers at their San Diego lab soon after China published the virus’ genetic code, is designed to trigger an immune response to COVID-19. Results of the trials are expected later this summer. If successful, a sufficient supply of vaccine doses is possible by the end of the year for further trials and emergency use.
Join Dr. Laurent Humeau, Chief Scientific Officer at Inovio, and Dr. John Ervin, Medical Director and Principal Investigator at the Center for Pharmaceutical Research, for an insider’s look at the COVID-19 vaccine trials underway in Kansas City that could end the pandemic and save countless lives.
Laurent Humeau, PhD, is Chief Scientific Officer at Inovio Pharmaceuticals, where he oversees the company’s pipeline of innovative concepts from early-stage discovery and development through clinical application and patient monitoring. Dr. Humeau holds a Ph.D., summa cum laude, from Denis Diderot/Paris 7 University and a MS degree from Pierre & Marie Curie/Paris 6 University, Paris, France.
John E. Ervin, MD, founded the Center for Pharmaceutical Research in 1986 and serves as Medical Director and Principal Investigator. During his career, he has conducted over 730 phase I through IV clinical trials. Dr. Ervin earned his undergraduate degree at the University of Notre Dame and received his medical degree from the University of Kansas School of Medicine.
Accessing the Program:
This free, online livestream lunch and learn will take place on June 2 at 4:00 pm CDT via Zoom. To help us better serve our audiences, we have included some demographic questions in the registration form. Your response to these questions is voluntary but appreciated. Thank you!Click here to register
Registration is currently open and will remain open until the event has ended. If you register in advance, you will receive an email with a link to join the session when it begins, or you may register and enter the program directly when you are ready to begin.
The Linda Hall Library encourages people of all abilities to enjoy our public programs. If you require reasonable accommodations in order to participate, please contact email@example.com or call 816.926.8753 in advance of the event.
Once you register for this event, you will receive email communications from the Linda Hall Library and the Linda Hall Library Foundation. You may choose to opt out of these communications at any time. Your contact information will not be sold or provided to any third parties.
The lecture will also livestream on the Library’s Facebook page.
Further reading at the Linda Hall Library
- Altenbaugh, Richard J. Vaccination in America: medical science and children’s welfare. Cham, Switzerland : Palgrave Macmillan, 2018.
- Smith, Charles G. (Charles Giles); O’Donnell, James, Pharm. D. The process of new drug discovery and development. New York : Informa Healthcare, 2006.
- Tauber, Alfred I. Immunity : the evolution of an idea . New York, NY, United States of America : Oxford University Press, 2017.
- Zimmerman, Barry E.; Zimmerman, David J. Killer germs : microbes and diseases that threaten humanity. Chicago : Contemporary Books, 2003.